maprotiline hydrochloride

Independent reference data for maprotiline hydrochloride (CAS 10347-81-6), compiled from public chemistry databases.

Registry identifiers across databases

Computed descriptors

Documented uses on record

For treatment of depression, including the depressed phase of bipolar depression, psychotic depression, and involutional melancholia, and may also be helpful in treating certain patients suffering severe depressive neurosis.A structurally and mechanistically diverse group of drugs that are not tricyclics or monoamine oxidase inhibitors. The most clinically important appear to act selectively on serotonergic systems, especially by inhibiting serotonin reuptake.

Synonyms and trade names

Maprotiline hydrochloride; 10347-81-6; Maprotiline Hcl; Ludiomil; 9-(gamma-Methylaminopropyl)-9,10-dihydro-9,10-ethanoanthracene hydrochloride; DTXSID2044507; 7C8J54PVFI; NSC-757085; 9,10-Ethanoanthracene-9(10H)-propanamine, N-methyl-, hydrochloride; BA-34276 HYDROCHLORIDE; Ba-34,276; N-Methyl-9,10-ethanoanthracene-9(10H)-propylamine hydrochloride; BA-34276; DTXCID0024507; 1-(3-Methylaminopropyl)dibenzo(b,e)bicyclo(2.2.2)octadiene hydrochloride; RefChem:57782

Regulatory listings held on file

GHS notification summary	2.3% (1 / 43)

GHS hazard classification

GHS notification summary	2.3% (1 / 43)
Reported hazard statements	H302 (97.7%)

This chemical does not meet GHS hazard criteria for 2.3% (1 of 43) of reports.

H302 (97.7%): Harmful if swallowed [Warning Acute toxicity, oral]

What the public record says

maprotiline hydrochloride · CAS 10347-81-6 · C20H24ClN. UNII 7C8J54PVFI.

Physical description and handling notes

Source: PubChem / Wikidata; the batch COA governs where values differ.